<DOC>
	<DOCNO>NCT01561482</DOCNO>
	<brief_summary>The purpose study find whether two drug use study , metformin simvastatin , slow speed rise prostate specific antigen ( PSA ) stop rise even bring level . Recently , scientist notice men take metformin treat high blood sugar simvastatin treat high cholesterol less likely develop prostate cancer . Also , scientist find , drug use preclinical study , slow growth prostate cancer cell . This study try find whether drug actually slow growth prostate cancer men .</brief_summary>
	<brief_title>Study Metformin With Simvastatin Men With Prostate Carcinoma</brief_title>
	<detailed_description>Men participate study take metformin simvastatin every day . Both drug pills take home . Subjects asked take metformin simvastatin metastasis prostate cancer appear PSA double start study . Primary Objective : To define efficacy , measure improvement PSA doubling time ( PSADT ) 6 month , combination metformin plus simvastatin patient recurrent prostate cancer follow definitive treatment . Secondary Objectives : 1 . To define time protocol-specified event men treat combination metformin plus simvastatin . 2 . To describe pattern change log PSA level PSA velocity time treatment metformin plus simvastatin . 3 . To describe association change metabolic parameter ( fast glucose/insulin/lipid panel/leptin/adiponectin others ) pattern change log PSA level .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>The study population consist subject undergone primary therapy ( prostatectomy primary radiation ) biopsyproven adenocarcinoma prostate biochemicalonly recurrence . 1 . Ability understand willingness sign write informed consent document . 2 . Male 18 year old . 3 . Histologically cytologically confirm diagnosis prostate cancer . 4 . Biochemical recurrence follow prostatectomy radiation prostate , define least 3 PSA rise , PSA determination least 4 week apart , PSA value great equal 0.2 ng/mL . 5 . PSA must less 50 ng/mL study entry . 6 . Screening PSA great equal 0.5 ng/mL men prostatectomy . Prior treatment neoadjuvant , adjuvant , salvage radiation therapy allow , , screen PSA great equal 0.5 ng/mL require eligibility . 7 . Screening PSA great equal 1.0 ng/mL postradiation nadir men treat primary radiation therapy ( external beam and/or brachytherapy ) . Men primary radiation therapy follow salvage prostatectomy eligible screen PSA great equal 0.5 ng/mL . 8 . PSA double time 3 36 month . 9 . Eastern Cooperative Oncology Group ( ECOG ) performance status less equal 2 ( Karnofsky great equal 60 % ) . 10 . Subjects must normal organ marrow function define : * Leukocytes great equal 3,000/mcL * Absolute neutrophil count great equal 1,500/mcL * Hemoglobin great equal 10 g/dL * Platelets great equal 100,000/mcL * Total bilirubin within normal institutional limit * AST ( SGOT ) /ALT ( SGPT ) less equal 1.5 X institutional upper limit normal * Creatinine within normal institutional limit OR creatinine clearance calculate great equal 60 mL/min/1.73 m2 subject creatinine clearance estimate creatinine level institutional glomerular filtration rate ( eGFR ) normal * Creatine phosphokinase ( CPK ) less equal institutional upper limit normal 11 . Ability swallow study drug . 12 . Life expectancy least 12 month . 13 . Subjects agree avoid grapefruit juice major inhibitor CYP3A4 . 1 . Evidence metastatic disease image study . 2 . Need treatment conventional modality prostate cancer ( surgery , radiation therapy , hormonal therapy ) . 3 . Prior hormonal therapy recurrent prostate cancer ( hormonal therapy give neoadjuvant adjuvant setting great 6 month entry acceptable ) . 4 . Prior chemotherapy prostate cancer . 5 . Treatment within last 30 day investigational drug . 6 . Radiation therapy within prior 6 month . 7 . Known hypersensitivity metformin statin . 8 . Subjects need take CYP3A4 inhibitor , cyclosporin , sirolimus , tacrolimus , verapamil , danazol , gemfibrozil , ketoconazole , macrolide antibiotic ( e.g. , azithromycin , clarithromycin , erythromycin ) exclude . Prior use agent acceptable , long stop least week prior study entry . 9 . Subjects need take CYP3A4 inducer , phenobarbital , dexamethasone , carbamazepine , phenytoin , rifampicin , nonnucleoside reverse transcriptase inhibitor ( e.g. , efavirenz , nevirapine , etravirine ) exclude . Prior use agent acceptable , long stop least week prior study entry . 10 . Prior history rhabdomyolysis . 11 . Prior history lactic acidosis . 12 . Any history myocardial infarction past 12 month . 13 . HIVpositive status . 14 . Subjects consume 3 alcoholic beverage per day . 15 . Subjects serious intercurrent illness , include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , nonmalignant medical psychiatric illness uncontrolled whose control may jeopardize complication therapy may limit compliance study requirement ( discretion investigator ) . 16 . Subjects diagnose treat another malignancy within 2 year prior study enrollment previously diagnose another malignancy still evidence residual disease . Subjects nonmelanoma skin cancer carcinoma situ type exclude undergone complete resection . 17 . Subjects currently treat metformin statin treat metformin statin past 6 month ineligible study . 18 . Subjects take 5areductase inhibitor ( finasteride dutasteride ) , saw palmetto , PCSPES within last 6 week ineligible study . Subjects take herbal supplement , vitamin , alternative medication eligible study long start 2 month prior study entry , remain stable regimen , remain stable regimen duration participation study . Men race ethnic group eligible trial .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Prostate carcinoma</keyword>
	<keyword>Prostate cancer</keyword>
	<keyword>Prostate Specific Antigen</keyword>
	<keyword>PSA</keyword>
	<keyword>Metformin</keyword>
	<keyword>Simvastatin</keyword>
	<keyword>Radiation therapy</keyword>
	<keyword>Prostatectomy</keyword>
</DOC>